First to market: Issue management pacesetters and the pharmaceutical industry response to AIDS in Africa

Business and Society

Volumn 44, Issue 3, 2005, Pages 244-282

  Dawkins, Cedric E ^a  

^a ASHLAND UNIVERSITY   (United States)

Author keywords

AIDS; Corporate social responsibility; Issue life cycle; Issue management; Pharmaceutical industry; Stakeholders

Indexed keywords

EID: 24944586453     PISSN: 00076503     EISSN: 14678594     Source Type: Journal    
DOI: 10.1177/0007650305275743     Document Type: Article

References (135)

1. Abrahamson, E. (1991). Managerial fads and fashions: The diffusion and rejection of innovations. Academy of Management Review, 16, 586-612.
2. Abrahamson, E., & Rosenkopf, L. (1990). When do bandwagon diffusions roll? How far do they go and when do they roll backwards? A computer simulation. Academy of Management Best Paper Proceedings, PP. 155-159.
3. Abrahamson, E., & Rosenkopf, L. (1993). Institutional and competitive bandwagons: Using mathematical modeling as a tool to explore innovation diffusion. Academy of Management Review, 18(3), 487-418.
4. Act Up Paris. (2002). Accelerating Access serves pharmaceutical companies while corrupting health organization. Retrieved April 28, 2004, from http://www.globaltreatmentaccess.org/content/press_releases/02/ 051502_APP_PS_WHO_ACC_ACC.html
5. Agence France Presse. (2001). AIDS regime considered too hard to follow. Retrieved November 22, 2004, from LexisNexis database.
6. AIDS Healthcare Foundation. (2003). Glaxo AZT case to be reopened. Media Release. Retrieved February 26, 2005, from http://www.aidshealth.org/newsroom/ press/press_archive/PR032103b.htm
7. Aldrich, H. E., & Fiol, C. M. (1994). Fools rush in? The institutional context of industry creation. Academy of Management Review, 19, 645-670.
8. Anderson, P. W., & Tushman, M. L. (1990). Technological discontinuities and dominant designs. Administrative Science Quarterly, 35, 604-633.
9. Ashforth, B. E., & Gibbs, B. W. (1990). The double-edge of organizational legitimation. Organization Science, 1, 177-194.
10. Backbier, E., Hoogstraten, J., & Terwogt-Kouwenhoven, K. M. (1997). Situational determinants of the acceptability of telling lies. Journal of Applied Social Psychology, 27(12), 1048-1062.
11. Banerjee, A. V. (1992). A simple model of herd behavior. Quarterly Journal of Economics, 3, 797-817.
12. Becker, E. (2003, August 31). Poor nations can purchase cheap drugs under accord. New York Times, p. C1.
13. Berman, S. (2001). Public affairs, issues management, and political strategy: Opportunities, opportunities, and more opportunities. Journal of Public Affairs, 1(4), 416-422.
14. Bhambri, A., & Sonnenfeld, J. (1988). Organization structure and corporate social performance: A field study in two contrasting industries. Academy of Management Journal, 31, 642-662.
15. Block, R. (2001, April 20). South Africa may reject use of aids drugs-having beaten back lawsuit, Pretoria now is hedging on antiretroviral agents. Wall Street Journal, p. A12.
16. Boseley, S. (2003). HIV and AIDS: Yusuf Hamied, generic drugs boss. Guardian. Retrieved February 18, 2003 from, http://www.guardian.co.uk/aids/ story/0,7369,898056,00.html
17. Brazilian edict weakens patent protection. (2003). Chain Drug Review, 25(16), 23.
18. Brint, S., & Karabel, J. (1991). Institutional origins and transformations: The case of American community colleges. In W. W. Powell & P. J. DiMaggio (Eds.), The new institutionalism in organizational analysis (pp. 337-360). Chicago: University of Chicago Press.
19. Brown, T. J., & Dacin, P. A. (1997). The company and the product: Corporate associations and consumer product responses. Journal of Marketing, 61, 68-84.
20. Buchholz, R., Evans, W. D., & Wagley, R. A. (1989). Management response to public issues. Englewood Cliffs, NJ: Prentice Hall.
21. Budd, J. W. (1995). The Internal Union political imperative for UAW pattern bargaining. Journal of Labor Research, 16, 43-53.
22. Burke, L., & Logsdon, J. (1996). How corporate social responsibility pays off. Long Range Planning, 29(4), 495-502.
23. Business Newswire. (2002). California congresswoman Diane Watson and AIDS healthcare foundation, America's largest HIV/AIDS medical provider say: "Glaxo: Do the right thing!". Retrieved November 22, 2004, from LexisNexis database.
24. Business Week Online. (2001). The stars of Asia-entrepreneurs: Yusuf Hamied, Chairman, Cipla Ltd. Retrieved April 26, 2004, from http://www. businessweek.com/magazine/content/01_27/b3739090.htm
25. Canadian Newspaper Association. (2003). Newspaper readership remains stable in 2003. Retrieved September 19, 2004, http://www.cna-acj.ca/client/cna/ cna.nsf/web/FactsReadership
26. Cole, R. E. (1985). The macropolitics of organizational change: A comparative analysis of the spread of small group activities. Administrative Science Quarterly, 30, 560-585.
27. Coleman, S. (2001). Dr. Yusuf Hamied: Generic drug maverick. Retrieved September 28, 2004, from http://www.worldpress.org/0701peoplehamied.htm
28. Collins, H. (2000, July). German drug company to offer Africans free AIDS treatment. Philadelphia Inquirer.
29. Cooper, S. G. (2001, March 9). Africa's AIDS war. New York Times, p. A1.
30. D'Aveni, R. A. (1994). Hyper-competition. New York: Free Press.
31. DiMaggio, P. J., & Powell, W. W. (1983). The iron cage revisited: Institutional isomorphism and collective rationality in organization fields. American Sociological Review, 48, 147-160.
32. Downs, A. (1977). Up and down with ecology. Public Interest, 28, 38-50.
33. Dozier, D. M. (1996, August). The environmental scanning function of public relations practitioners and participation in management decision making. Paper presented at the Public Relations Division Association for Education in Journalism and Mass Communication meeting, Norman, OK.
34. Drumwright, M. D. (1994). Socially responsible organizational buying: Environmental concern as a noneconomic buying criterion. Journal of Marketing, 58, 1-19.
35. Dutton, J. E., & Duncan, R. B. (1987). The creation of momentum for change through the process of strategic issue diagnosis. Strategic Management Journal, 8, 279-295.
36. Dyer, G. (2003). Moral dilemma for pharma. Financial Times of London. Retrieved August 18, 2004, from LexisNexis database.
37. Elsbach, K. D., & Sutton, R. I. (1992). Acquiring organizational legitimacy through illegitimate actions: A marriage of institutional and impression management theories. Academy of Management Journal, 35, 699-738.
38. Fligstein, N. (1991). The structural transformation of American industry: An institutional account of the causes of diversification of the largest firms, 1919-1979. In W. W. Powell & P. J. DiMaggio (Eds.), The new institutionalism in organizational analysis (pp. 311-336). Chicago: University of Chicago Press.
39. Frooman, J. (1999). Stakeholder influence strategies. Academy of Management Review, 24, 191-206.
40. Gamson, W., & Modigliani, A. (1989). Media discourse and public opinion on nuclear power: A constructionist approach. American Journal of Sociology, 95(1), 1-37.
41. Garud, R., Jain, S., & Kumaraswamy, A. (2002). Institutional entrepreneurship in the sponsorship of common technological standards: The case of Sun Microsystems and Java. Academy of Management Journal, 45, 196-214.
42. Garud, R., & Karnoe, P. (2002). Bricolage vs. breakthrough: Distributed and embedded agency in technology entrepreneurship. Research Policy, 32, 277-301.
43. Gellman, B. (2000a, December 28). A turning point that left millions behind. Washington Post, p. A01.
44. Gellman, B. (2000b, December 28). An unequal calculus of life and death: As millions perished in pandemic, firms debated access to drugs. Washington Post, p. A18.
45. Gerde, V. W., & White, C. G. (2003). Auditor independence, accounting firms, and the securities and exchange commission: Application of the issue life cycle model. Business & Society, 42, 83-114.
46. Goodstein, J., & Boeker, W. (1991). Turbulence at the top: A new perspective on governance structures and strategic change. Academy of Management Journal, 34, 306-330.
47. Granovetter, M. (1985). Economic action and social structure: The problem of embeddedness. American Journal of Sociology, 91, 481-510.
48. Greening, D. W., & Gray, B. (1994). Testing a model of organizational response to social and political issues. Academy of Management Journal, 37, 467-498.
49. Greenwood, R., & Minings, C. R. (1996). Understanding radical organizational change: Bringing together the old and the new institutionalism. Academy of Management Review, 21, 1022-1054.
50. Greenwood, R., Hinings, C. R., Suddaby, R. (2002). Theorizing change: The role of professional associations in the transformation of institutionalized fields. Academy of Management Journal, 45, 58-80.
51. Hensley, S. (2003). Pharmacia nears deal to sell cheaper version of AIDS drug to undeveloped nations. Retrieved January 23, 2004, from www.natap.org/2003/Jan/012403_1.htm
52. Hilgartner, S., & Bosk, C. (1988). The rise and fall of social problems: A public arena model. American Journal of Sociology, 94(1), 53-78.
53. Hirsch, P. M., & Lounsbury, M. (1997). Ending the family quarrel: Toward a reconciliation of "old" and "new" institutionalisms. American Behavioral Scientist, 40, 406-418.
54. Hohler, B. (1997, September 14). 23 ask that tobacco pact spare Liggettt [City edition]. Boston Globe, p. A09.
55. International Energy Agency. (2004). International Energy Agency workshop: Seeking frontiers on highly efficient energy utilisation in factories and buildings. Retrieved May 5, 2004, from http://www.eccj.or.jp/intnl/ 03workshop/index_e.html
56. IRINnews.org. (2002). South Africa: HIV/AIDS lobby group on hunger strike. Retrieved September 21, 2004, http://www.irinnews.org/report.asp? ReportID=31530
57. Jacobs, D. (1974). Dependency and vulnerability: An exchange approach to the control of organizations. Administrative Science Quarterly, 19, 45-59.
58. Jaworski, B. J., & Kohli, A. K. (1993). Market orientation: Antecedents and consequences. Journal of Marketing, 57, 53-71.
59. Jones, J. (1983). What are the issues? Business Quarterly, 22(3), 22-31.
60. Jones, T. (1997, April 25). Good works, good business. USA Today, p. 1B.
61. Kirby, E. J. (2003). Drug company launches AIDS programme. BBC News. Retrieved January 23, 2004, from http://news.bbc.co.Uk/1/hi/business/2692405.stm
62. Knoke, D. (1982). The spread of municipal reform: Temporal, spatial and social dynamics. American Journal of Sociology, 87, 1314-1339.
63. Krauskopf, L. (2001, March 8). AIDS activists praise Merck's cut of some drug prices in Africa. The Record.
64. Krauskopf, L. (2003, January 25). New Jersey-based Pharmacia expands access to AIDS drug. The Record.
65. Lattin, J. M., & Roberts, J. H. (1989). Modeling the role of risk-adjusted utility in the diffusion of innovations (Working Paper No. 1019). Stanford, CA: Stanford University, Graduate School of Business.
66. Lawrence, T. B. (1999). Institutional strategy. Journal of Management, 25, 161-187.
67. Leblebici, H., Salancik, G. R., Copay, A., & King, T. (1991). Institutional change and the transformation of interorganizational fields: An organizational history of the U.S. radio broadcasting industry. Administrative Science Quarterly, 36, 333-363.
68. Lewis, C. & the Center for Public Integrity (2000). The buying of the president 2000. Washington, DC: Center for Public Integrity.
69. Litz, R. A. (1996). A resource-based view of the socially responsible firm: Stakeholder interdependence, ethical awareness, and issue responsiveness as strategic assets. Journal of Business Ethics, 15, 1355-1363.
70. Lounsbury, M. (1999). Field transformation and population recomposition: The dynamics of professional and business associations in the U. S. field of finance, 1945-1993. Paper presented at the 59th Annual Meeting of Academy of Management, Chicago, IL.
71. Mahon, J. F., & Waddock, S. A. (1992). Strategic issues management: An integration of issue life. Business & Society, 37(1), 19-33.
72. March, J. G., & Olsen, J. P. (1976). Ambiguity and choice in organizations. Bergen, Norway: Universitetsforlaget.
73. Martin, K. (2001). Eyewitness South Africa: Leaders condemn U.S. on AIDS drug policy. Retrieved April 26, 2004, from http://www.peoplesvideo.org/sa_hiv. htm
74. McCombs, M. (1994). News influence on our pictures of the world. In J. Bryant & D. Zillman (Eds.), Media effects: Advances in theory and research (pp. 1-16). Hillsday, NJ: Lawrence Erlbaum.
75. McCombs, M., & Shaw, D. (1974, April). A progress report on agenda-setting research., Paper presented at the Association for Education in Journalism meeting, San Diego.
76. McGee, J., & Thomas, H. (1986). Strategic groups: Theory, research and taxonomy. Strategic Management Journal, 7, 141-160.
77. McNeil, D. (2001). Indian company offers to supply AIDS drugs at low cost in Africa. New York Times. February 7.
78. Mdyogolo, J. (2002, December 30). AIDS activists stage Black Christmas hunger strike. Star, p. 2. Retrieved September 28, 2004, http://www.hivan.org. za/resources/resources.asp?Page_no=34&id=6
79. Menon, A., & Menon, A. (1997). Enviropreneurial marketing strategy: The emergence of corporate environmentalism as marketing strategy. Journal of Marketing, 61, 51-67.
80. Merck & Co. (2001). Merck & Co., Inc., announces significant reductions in prices of HIV medicines to help speed access in developing world. Retrieved November 18, 2004, http://www.prnewswire.co.uk/cgi/news/release?id= 64189
81. Merriam, S. B. (1985). The case study in educational research: A review of selected literature. Journal of Educational Thought, 19(3), 204-217.
82. Meyer, A. D. (1982). Adapting to environmental jolts. Administrative Science Quarterly, 27, 515-537.
83. Meyer, A. D., Brooks, G. R., & Goes, J. B. (1990). Environmental jolts and industry revolutions: Organizational responses to discontinuous change. Strategic Management Journal, 11, 93-110.
84. Meyer, J., & Rowan, B. (1977). Institutionalized organizations: Formal structure as myth and ceremony. American Journal of Sociology, 83, 340-363.
85. Miles, M., & Huberman, M. (1984). Qualitative data analysis: A source book for new methods. Thousand Oaks, CA: Sage.
86. Mintzberg, H. (1983). Power in and around organizations. Englewood Cliffs, NJ: Prentice Hall.
87. Mitchell, R. K., Agle, B. R., & Wood, D. (1997). Toward a theory of stakeholder identification and salience: Defining the principle of who and what really counts. Academy of Management Review, 22, 853-886.
88. Molowa, D. T. (1997). Biotechnology industry: HIV antivirals market -industry report. New York: Bear Stearns & Co.
89. Oliver, C. (1991). Strategic responses to institutional processes. Academy of Management Review, 16, 145-179.
90. Oxfam. (2001 a). Patent injustice: How world trade rules threaten the health of poor people. Oxford, UK: Oxfam.
91. Oxfam. (2001b). Dare to Lead: Public health and company wealth. Retrieved April 26, 2004, from http://www.oxfam.org.uk/what_we_do/issues/health/ dare_to_lead.htm
92. Pangarkar, N., & Klein, S. (1998). Bandwagon pressures and interfirm alliances in the global pharmaceutical industry. Journal of International Marketing, 6(2), 86-108.
93. Pharma puts on a human face: Pharmaceutical companies are doing more than ever to communicate their value. (2003). Med Ad News, 22(6), 4.
94. Porac, J., Rosa, J., Spanjol, J., & Saxon, M. (2001). America's family vehicle: Path creation in the U.S. minivan market. In R. Garud & P. Karnoe (Eds.), Path dependence and creation (pp. 213-242). Hillsdale, NJ: Lawrence Erlbaum.
95. Porter, M. E. (1980). Competitive strategy. New York: Free Press.
96. Porter, M. E. (1990). The competitive advantage of nations. New York: Free Press.
97. Porter, M. E., & van der Linde, C. (1995). Green and competitive: Beyond the stalemate. Harvard Business Review, 73(5), 120-134.
98. PR Newswire. (2003). AIDS healthcare foundation's federal lawsuit against British drug giant GlaxoSmithKline over patent piracy on AIDS drug AZT to move forward: Federal court rejects GSK motion to dismiss AZT patent lawsuit. Retrieved February 28, 2004, http://www.prnewswire.co.uk/cgi/news/release?id= 105872
99. PR Newswire. (2004). California AG supports AHF's efforts in lawsuit against GSK on AZT patent. Retrieved February 24, 2004, from http://www.aegis.com/news/pr/2004/PR040218.html
100. Rands, G. P. (1991, April). The corporate social performance model, revisited. Paper presented at the International Association of Business and Society meeting, Sundance, UT.
101. Reuters. (2001, October 9). GlaxoSmithKline gives aids drug rights to generic maker. New York Times, p. C4.
102. Reuters. (2003). Brazil opens door to import generic AIDS drugs. Retrieved January 26, 2004, from http://12.31.13.115/HealthNews/reuters/ NewsStory0905200317.htm
103. Rochefort, D. A., & Cobb, R. W. (1994). The politics of problem definition: Shaping the policy agenda. Lawrence: University of Kansas Press.
104. Rogers, E. M. (1995). Diffusion of innovation (4th ed.). New York: Free Press.
105. Rowan, B. (1982). Organization structure and the institutional environment: The case of public schools. Administrative Science Quarterly, 27, 259-279.
106. Rowley, T. J. (1997). Moving beyond dyadic ties: A network theory of stakeholder influences. Academy of Management Review, 22, 887-911.
107. Salancik, G., & Pfeffer, J. (1978). The external control of organizations. New York: Harper & Row.
108. Saponara, A. (1995). Competitive advantage in the environment. Journal of Environmental Leadership: Corporate Environmental Strategy, 3(1), 32-38.
109. Scott, W. R. (1995). Institutions and organizations. Thousand Oaks, CA: Sage.
110. Sellers, L. J., Feighan, C., & Kelley, G. (2002). Top 50 pharmaceutical companies of 2001. Pharmaceutical Executive, 22(5), p. 60.
111. Shaffer, W. E., Quasney, T. J., & Grimm, C. M. (2000). Firm level performance implications of nonmarket actions. Business & Society, 39, 126-143.
112. Sherer, P. D., & Lee, K. (2002). Institutional change in large law firms: A resource dependency and institutional perspective. Academy of Management Journal, 45, 102-119.
113. Smith, C. (1996, September 8). Corporate citizens and their critics. New York Times, p. 11.
114. Sparshott, J. (2002, December 25). United States refusal thwarts WTO drug-patent talks. Washington Times, p. C10.
115. Sparshott, J. (2003, July 1). U.S. drug industry shifts position on global trade agreements on generic drugs. Washington Times, p. C8.
116. Strang, D., & Meyer, J. W. (1993). Institutional conditions for diffusion. Theory and Society, 22, 487-511.
117. Suchman, M. C. (1995). Managing legitimacy: Strategic and institutional approaches. Academy of Management Review, 20, 571-610.
118. Swarns, R. L. (2001, March 8). AIDS drug battle deepens in Africa. New York Times, pp. A1-A6.
119. Symonds, W. C. (2000). The gun deal is half-cocked. Business Week. Retrieved August 21, 2004, from http://www.businessweek.com/archives/2000/ b3675111.arc.htm
120. Thornton, P. H. (1995). Accounting for acquisition waves: Evidence from the U.S. publishing industry. In W. R. Scott & S. Christensen (Eds.), The institutional construction of organizations (pp. 195-225). Thousand Oaks, CA: Sage.
121. Tolbert, P. S., & Zucker, L. G. (1983). Institutionalization of institutional theory. In S. Clegg, C. Hardy, & W. Nord (Eds.), The handbook of organization studies (pp. 175-190). Thousand Oaks, CA: Sage.
122. The top 500 prescription drugs by therapeutic category: AIDS and AIDS-related drugs. (2000). Med Ad News, 19(5), 65.
123. Tushman, M. J., & Anderson, P. (1986). Technological discontinuities and organization environments. Administrative Science Quarterly, 31, 439-465.
124. UNAIDS. (2000). One million more living with aids in sub-Saharan Africa, new report reveals. Retrieved April 26, 2004, from http://www.thebody.com/ unaids/subsaharan_africa.html
125. UNAIDS. (2004). UNAIDS 2004 report on the global AIDS epidemic. Retrieved September 28, 2004, from http://www.unaids.org/bangkok2004/report.html
126. Verschoor, C. C. (1998). A study of the link between a corporation's financial performance and its commitment to ethics. Journal of Business Ethics, 17, 1509-1516.
127. Vivienne, W. (2001). AIDS drug war heats up. Fortune, 143(14), 48-49.
128. Wartick, S. L. (1992). The relationship between intense media exposure and change in corporate reputation. Business & Society, 31(1), 33-49.
129. Wartick, S. L., & Mahon, J. F. (1994). Toward a substantive definition of the corporate issue construct: A review and synthesis of the literature. Business & Society, 33, 293-311.
130. Wartick, S. L., & Rude, R. (1986). Issues management: Corporate fad or corporate function? California Management Review, 29(1), 124-140.
131. Wasserman, S., & Galaskiewicz, J. (1994). Advances in social network analysis: Research in the social and behavioral sciences. Thousand Oaks, CA: Sage.
132. Wayne, L. (2000, March 8). Gun makers see betrayal in decision by Smith & Wesson. New York Times, p. A8.
133. Webley, S., & More, E. (2003). Does business ethics pay?. Retrieved March 7, 2005, from http://www.ibe.org.uk/DBEPsumm.htm
134. Yin, R. (1994). Case study research: Design and methods (2nd ed.). Thousand Oaks, CA: Sage.
135. Zeitz, G., Vikas, M., & McAulay, B. (1999). Distinguishing adoption and entrenchment of management practices: A framework for analysis. Organization Studies, 20(5), 741-776.